Valuation: Bayer AG

Market Cap 47.4B 54.59B 44.2B 40.6B 76.79B 5,193B 77.63B 521B 204B 2,596B 205B 201B 8,601B P/E 2026 *
20.4x
P/E 2027 * 15.7x
Enterprise Value 75.98B 87.51B 70.84B 65.08B 123B 8,324B 124B 835B 327B 4,161B 329B 321B 13,787B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.61x
Free-Float
100%
Yield 2026 *
0.28%
Yield 2027 * 1.24%
1 day+0.66%
1 week+2.59%
Current month+0.42%
1 month-9.58%
3 months+29.01%
6 months+6.87%
Current year+30.37%
1 week 46.96
Extreme 46.96
49.92
1 month 45.49
Extreme 45.49
53.78
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
3/18/26 A Buy

Chief Executive Officer

21,050 0.0021%
7/16/25 A Buy

Executive/Senior Manager

1,501 0.0002%
7/16/25 A Buy

Executive/Senior Manager

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.05%+2.59%+75.49%-6.53% 54.59B
-0.51%-8.60%+45.08%+148.21% 995B
+0.20%-4.42%+49.05%+50.81% 614B
-0.53%-7.37%+23.64%+65.03% 431B
+0.64%-2.77%+40.27%+34.96% 353B
+0.24%-4.45%+31.74%+39.89% 293B
-0.21%-9.27%+5.42%+7.61% 245B
-1.82%-8.29%-1.73%-42.05% 210B
+2.94%-0.78%+29.17%+60.32% 210B
+3.13%+0.69%+18.11%+71.90% 168B
Average +1.13%-4.26%+31.62%+43.01% 357.28B
Weighted average by Cap. +0.73%-5.76%+34.41%+69.45%

Financials

2026 *2027 *
Net sales 45.63B 52.55B 42.55B 39.08B 73.92B 4,999B 74.73B 502B 196B 2,499B 197B 193B 8,280B 46.8B 53.9B 43.64B 40.09B 75.81B 5,127B 76.65B 514B 201B 2,563B 202B 198B 8,492B
Net income 2.18B 2.51B 2.03B 1.86B 3.53B 239B 3.57B 23.93B 9.36B 119B 9.42B 9.21B 395B 2.92B 3.36B 2.72B 2.5B 4.73B 320B 4.78B 32.1B 12.55B 160B 12.63B 12.35B 530B
Net Debt 28.58B 32.92B 26.65B 24.48B 46.3B 3,131B 46.81B 314B 123B 1,565B 124B 121B 5,186B 27.9B 32.13B 26.01B 23.9B 45.2B 3,057B 45.69B 307B 120B 1,528B 121B 118B 5,063B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
04/08/26 48.25 +2.40% 3,775,982
03/08/26 €47.12 -1.94% 2,881,610
31/07/26 €48.05 -0.81% 2,153,646
30/07/26 €48.44 +1.57% 1,932,719
29/07/26 €47.69 +1.40% 1,749,807
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.25EUR
Average target price
55.58EUR
Spread / Average Target
+15.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock